3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
77
Carcinoma, Hepatocellular
48
Ovarian Neoplasms
41
Carcinoma, Non-Small-Cell Lung
26
Neoplasms
22
Fallopian Tube Neoplasms
17
Lung Neoplasms
15
Breast Neoplasms
13
Neoplasm Metastasis
12
Glioblastoma
12
Endometrial Neoplasms
12
Colonic Neoplasms
11
Brain Neoplasms
11
Uterine Cervical Neoplasms
10
Triple Negative Breast Neoplasms
10
Rectal Neoplasms
10
Liver Neoplasms
9
Stomach Neoplasms
8
Colorectal Cancer Metastatic
7
Pancreatic Neoplasms
6
Advanced Solid Tumors
6
Recurrence
5
Melanoma
5
Glioma
5
Carcinoma, Renal Cell
5
Carcinoma, Ovarian Epithelial
5
Biliary Tract Neoplasms
5
Solid Tumor
4
Meningeal Carcinomatosis
4
Adenocarcinoma of Lung
4
Interventions
palbociclib
1
microcrystalline cellulose
1
epigallocatechin gallate
1
dapagliflozin
1
Vitamin D
1
Tablets
1
Specimen Handling
1
Selenium
1
Saline Solution
1
Pregabalin
1
Platelet Count
1
Plastic Surgery Procedures
1
Omeprazole
1
Losartan
1
Ketorolac
1
Infliximab
1
Immunotherapy, Adoptive
1
Dexmedetomidine
1
Cognitive Behavioral Therapy
1
Calcium
1
Bevacizumab
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Inflammation
×
Bevacizumab
×
Clear all
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled